BFLY · Butterfly Network, Inc.
$8.64
-0.40 (-4.42%)
At close · Aug 26
Market Cap
$2.42B
Shares
266.29M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$97.61M
+19%
FY2025
Net Income
-$77.06M
-6.3%
FY2025
Gross Margin
46.85%
-12.7pp
FY2025
Operating Margin
-88.53%
+2.2pp
FY2025
Diluted EPS
-$0.31
+8.8%
FY2025
Operating Cash Flow
-$12.7M
+69.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|
| $119M – $123M | $112.14M | $97.61MG | $82.06M | $65.9MG | $73.39MG | $62.57M | $46.25M | $27.58M | |
| — | $53.11M | $51.88M | $33.23M | $49.04M | $33.93M | $45.51M | $107.48M | $48.48M | |
| — | $59.04M | $45.73M | $48.83M | $16.86M | $39.46M | $17.05M | -$61.22M | -$20.9M | |
| — | — | 46.85% | 59.51% | 25.58% | 53.77% | 27.26% | -132.37% | -75.75% | |
| — | $38.1M | $36.26M | $37.8M | $55.62M | $88.04M | $74.46M | $49.74M | $48.93M | |
| — | $45.58M | $45.88M | $41.57M | $39.07M | $59.49M | $49.6M | $26.26M | $14.28M | |
| — | $42.68M | $39.24M | $39.81M | $49.61M | $77.6M | $85.72M | $24.4M | $18.19M | |
| — | — | — | — | — | $3.3M | $500K | — | — | |
| — | — | $6.7M | $8.9M | $8.7M | $5.9M | $2.1M | $1.32M | $758K | |
| — | $138.42M | $132.15M | $123.24M | $162.47M | $232.48M | $209.78M | $100.4M | $81.4M | |
| — | -$79.38M | -$86.42M | -$74.41M | -$145.61M | -$193.02M | -$192.73M | -$161.62M | -$102.3M | |
| — | — | -88.53% | -90.68% | -220.96% | -263.01% | -308.04% | -349.43% | -370.87% | |
| — | — | -$79.72M | -$65.51M | -$136.91M | -$187.12M | -$190.63M | -$160.3M | -$101.54M | |
| — | $1.34M | $1.49M | $1.26M | $0 | $2000 | $651K | $1.14M | — | |
| — | $5.02M | $5.91M | $5.02M | $7.45M | $3.38M | $2.57M | $285K | $2.7M | |
| — | -$308K | $2.77M | -$13K | -$2000 | $98K | -$2.58M | -$231K | -$96K | |
| — | -$74.77M | -$76.95M | -$72.52M | -$133.62M | -$168.68M | -$32.29M | -$162.71M | -$99.7M | |
| — | $83K | $110K | -$32K | $82K | $42K | $121K | $39K | — | |
| — | -$74.85M | -$77.06M | -$72.49M | -$133.7M | -$168.72M | -$32.41M | -$162.75M | -$99.7M | |
| — | — | -78.95% | -88.34% | -202.88% | -229.9% | -51.8% | -351.87% | -361.44% | |
| — | -$74.85M | -$77.06M | -$72.49M | -$133.7M | -$168.72M | -$32.41M | -$162.75M | — | |
| — | -$74.85M | -$77.06M | -$72.49M | -$133.7M | — | — | — | — | |
| USD/shares | — | — | -$0.31 | -$0.34 | -$0.65 | -$0.84 | -$0.19 | -$26.87 | -$17.08 |
| USD/shares | — | — | -$0.31 | -$0.34 | -$0.65 | -$0.84 | -$0.19 | -$26.87 | -$17.08 |
| shares | — | — | 247.12M | 211.68M | 205.39M | 199.85M | 173.81M | 6.06M | 5.84M |
| shares | — | — | 247.12M | 211.68M | 205.39M | 199.85M | 173.81M | 6.06M | 5.84M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 3.08×
EV/EBIT
—
Peer median 22.99×
P/E (TTM)
—
Peer median 28.38×
Peer medians compare against the 58 similar-size Medical Devices companies (of 145 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Reportable Segment | $97,610,000 | $82,056,000 | $65,900,000 | $73,390,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| United States | $77,437,000 | $63,423,000 | $52,116,000 | $51,072,000 | $42,993,000 | $33,237,000 | $23,997,000 |
| Non Us | $20,173,000 | $18,633,000 | $13,784,000 | $22,318,000 | $19,572,000 | $13,015,000 | $3,586,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Product | $63,443,000 | $54,200,000 | $40,036,000 | $50,263,000 | $47,868,000 | $38,347,000 | $25,081,000 |
| Software and Other Services | $34,167,000 | $27,856,000 | $25,864,000 | — | — | — | — |
| Service Other | — | — | — | $23,127,000 | $14,697,000 | $7,905,000 | — |
| Subscription And Circulation | — | — | — | — | — | — | $2,502,000 |
Key facts
CIK
1804176
CUSIP
124155102
13F (30d)
211 filings
208 filers
Visit website
Investor relations